FibroBiologics, Inc., based in Houston, is scheduled to present at a conference in New York City.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FibroBiologics, Inc., based in Houston, is scheduled to present at a conference in New York City.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Charles River Laboratories secured a contract to produce FibroBiologics' CYWC628 product as a Contract Development and Manufacturing Organization (CDMO).Sub-event
FibroBiologics is based in Houston and presenting in NYC.1 source
Keep exploring
The entities involved
-
Houston
seat of Harris County, and largest city in State of Texas, United States
-
New York City
most populous city in the United States
Coverage
Newest first; wire copies grouped- GlobeNewswireFibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference HOUSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical